National Comprehensive Cancer Network

|
|
|
|
For Patients

About NCCN

Myeloid Growth Factors Panel

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Jeffrey Allen, MD

None

None

None

None

7/1/2009

James Armitage, MD

None

None

None

None

12/15/2008

Lodovico Balducci, MD

None

Amgen Inc.;
Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
sanofi-aventis U.S.

None

None

11/5/2009

Charles L. Bennett, MD, PhD, MPP

None

sanofi-aventis U.S.

None

None

11/3/2009

Douglas W. Blayney, MD

None

Amgen Inc.;
Bristol-Myers Squibb Company

None

American Society of Clinical Oncology;
University of Michigan

7/1/2009

Spero R. Cataland, MD

None

None

None

None

12/15/2008

Jeffrey Crawford, MD

Celgene Corporation;
Facet Biotech;
Hoffman LaRoche

Amgen Inc.;
Eisai Inc.;
Eli Lilly and Company;
Genentech, Inc.;
Morphotek Inc.;
Acceleron;
Aggenix;
Chugai;
EMD Serono;
Proventys

None

None

11/4/2009

David C. Dale, MD

Amgen Inc.;
AnorMED Inc.;
Genzyme Corporation;
Schering-Plough Corporation

Amgen Inc.;
AnorMED Inc.;
Genzyme Corporation;
caremark;
Cellerant;
Schering-Plough Corporation;
Telik, Inc.

None

None

12/15/2008

George Daniel Demetri, MD

None

Amgen Inc.;
ARIAD Pharmaceuticals, Inc.;
Bayer HealthCare;
Bristol-Myers Squibb Company;
Daiichi- Sankyo Co.;
Genentech, Inc.;
Johnson & Johnson;
Novartis Pharmaceuticals Corporation;
Alnylam;
EMD-Serono;
Idera;
Infinity Pharmaceuticals;
Kolltan Pharmaceuticals;
N-of-One;
PamGene;
Plexxikon;
ZioPharm;
Pfizer Inc.

None

None

10/27/2009

Mary Dwyer Rosario, MS

None

None

None

None

7/1/2009

Harry P. Erba, MD, PhD

Cephalon, Inc.;
Eli Lilly and Company;
Exelixis Inc.;
Genzyme Corporation;
Kanisa Pharmaceuticals, Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Wyeth Pharmaceuticals;
Xanthus Pharmacueuticals, Inc.

Bristol-Myers Squibb Company;
Celgene Corporation;
Cephalon, Inc.;
Genzyme Corporation;
MGI PHARMA, INC.;
Novartis Pharmaceuticals Corporation;
Pharmion Corporation

None

National Cancer Institute

11/17/2009

James M. Foran, MD

Genzyme Corporation;
Ambit BioSciences;
Astex Therapeutics;
Seattle Genetics

Celgene Corporation;
Genzyme Corporation;
Astex Therapeutics

None

None

10/28/2009

Lauren Gallagher, PhD

None

None

None

None

8/28/2009

Marti Goemann, RPh

None

None

None

None

9/28/2009

Kristina M Gregory, RN, MSN, OCN

None

None

None

None

8/21/2009

Mark L. Heaney, MD, PhD

None

None

None

None

12/15/2008

Maria Ho, PhD

None

None

None

None

7/1/2009

Sally L. Htoy, PharmD

None

None

None

None

12/15/2008

Susan Hudock, BS, PharmD, BCOP

None

None

None

None

7/1/2009

Dwight D. Kloth, PharmD, FCCP, BCOP

None

Amgen Inc.;
Eisai Inc.;
GlaxoSmithKline;
Ortho Biotech Products, L.P.

None

None

8/13/2009

David J. Kuter, MD

None

Amgen, Inc;
Caremark

None

None

7/1/2009

Gary H. Lyman, MD, MPH

Amgen Inc.

Amgen Inc.

None

None

7/29/2009

Joan S McClure, MS

None

None

None

None

9/28/2009

Sarah C. Miyata, RN, MSN, ACNP-CS

None

None

None

None

10/2/2009

Martin S. Tallman, MD

None

Genzyme Corporation

None

None

10/28/2009

Saroj Vadhan-Raj, MD

Amgen Inc.

Amgen Inc.

None

None

12/15/2008

Peter Westervelt, MD, PhD

None

Celgene Corporation;
Novartis Pharmaceuticals Corporation

None

None

10/6/2009

Michael Westmoreland, PharmD

None

Merck & Co., Inc.;
Pfizer Inc.

None

None

7/17/2009

Michael K. Wong, MD, PhD

None

Novartis Pharmaceuticals Corporation;
Schering-Plough Corporation

None

None

9/28/2009

 

NCCN Website Supporters